Skip to main content

Table 1 Patients’ baseline characteristics

From: The prognostic value of postoperative blood glucose in non-diabetic patients with rheumatic heart disease

Clinical variables

Postoperative BG level (mmol/L)

Quartile 1 (n = 348)

Quartile 2 (n = 354)

Quartile 3 (n = 341)

Quartile 4 (n = 352)

P

Age (year)

56.3 ± 5.7

57.2 ± 5.5

57.5 ± 5.7

58.0 ± 5.5

0.001

Males, n (%)

138 (39.7)

117 (33.1)

108 (31.7)

96 (27.3)

0.006

Smoking, n (%)

37 (10.6)

42 (11.9)

30 (8.8)

36 (10.2)

0.618

Hypertension, n (%)

29 (8.3%)

30 (8.5)

39 (11.4)

40 (11.4)

0.319

NYHA III-IV, n (%)

148 (42.5)

129 (36.4)

162 (47.5)

164 (46.6)

0.012

FBG (mmol/L)

4.7 ± 0.5

4.8 ± 0.6

4.9 ± 0.6

4.9 ± 0.6

<0.001

Postoperative glucose (mmol/L)

8.1 ± 1.0

10.1 ± 0.5

12.0 ± 0.7

15.8 ± 2.0

<0.001

Serum creatinine (umol/L)

83.4 ± 29.7

78.6 ± 22.3

79.6 ± 24.6

81.5 ± 25.7

0.069

lgCRP (mg/L)

0.5 ± 0.4

0.5 ± 0.4

0.5 ± 0.4

0.6 ± 0.4

0.006

Glycated hemoglobin (%)

5.8 ± 0.4

5.8 ± 0.4

5.8 ± 0.4

5.8 ± 0.4

0.222

LVEF (%)

61.7 ± 8.6

62.1 ± 8.6

62.5 ± 8.5

60.7 ± 10.3

0.047

Type of surgery

 Aortic valve replacement

170 (48.9)

163 (46.0)

189 (55.4)

198 (56.3)

0.015

 Mitral valve replacement

331 (95.1)

318 (95.5)

314 (92.1)

326 (92.6)

0.174

 Tricuspid intervention

270 (77.6)

275 (77.7)

254 (74.5)

271 (77.0)

0.730

 CABG

13 (3.7)

12 (3.4)

14 (4.1)

20 (5.7)

0.445

In-hospital death

4 (1.1)

8 (2.3)

6 (1.8)

29 (8.2)

<0.001

In-hospital MACEs

7 (2.0)

11 (3.1)

9 (2.6)

34 (9.7)

<0.001

  1. NYHA New York Heart Association, FBG Fasting blood glucose, CRP C-reactive protein, LVEF Left ventricular ejection fraction, CABG Coronary artery bypass grafting, MACEs Major adverse clinical events